A nested PCR protocol to detect Mycoplasma pneumoniae DNA in throat specimens was developed. An amplification control (AC) template, which is amplified by the same primers as the M. pneumoniae target sequence, was constructed. The assay allowed highly specific and sensitive detection of M. pneumoniae DNA. In all, 305 throat samples, 62 from hospitalised patients and 243 from non-hospitalised subjects, were analysed by the nested PCR. Inhibition of the PCR was observed in 20% of the samples, but was abolished after a 1 in 10 dilution. Throat samples from 5 (8%) of the hospitalised patients and from 7 (3%) of the non-hospitalised subjects were positive for M. pneumoniae DNA. To investigate the relationship between M. pneumoniae load and the severity of disease, the M. pneumoniae load in 10 throat samples from M. pneumoniae-positive subjects was assessed semi-quantitatively by application of the nested PCR to a series of limiting dilutions of nucleic acid extracted from these throat samples. The calculated M. pneumoniae load varied from 20 to 3830cfu/ml of throat sample. The mean M. pneumoniae load in samples from the hospitalised patients was significantly higher than that in samples from the non-hospitalised subjects. The nested PCR is a useful tool to detect M. pneumoniae DNA in the throat and to study the relationship between the load of M. pneumoniae in throat samples and severity of disease due to M. pneumoniae infection.
Introduction
Mycoplasma pneurnoniae is a common cause of upper and lower respiratory tract infections in man. The majority of these infections are relatively mild, but serious disease like pneumonia can require hospitalisation. Complications of the primary infection, e.g., neurological and cardiovascular complications, can also occur [ 1-31. M. pneumoniae infection is diagnosed routinely by serological methods or by culture, or by both. Because these diagnostic approaches have disadvantages, such as repeated blood sampling to perform reliable serology [4] and the slow growth of M. pneumoniae in culture, molecular diagnostic techniques have been applied to the laboratory diagnosis of M. pneumoniae infection. Both DNA hybridisation techniques [5-81 and the PCR [5, have been used.
The clinical significance of a positive PCR result for M. pneumoniae in throat specimens obtained from patients can be obscured by the fact that M. pneumoniae can persist in the throat after symptomatic infection [ 151 and even after antibiotic treatment [8] . As a relationship between high levels of M. pneumoniae in the throat and clinically significant respiratory tract infection has been observed [8, 131, molecular diagnostic methods that allow detection of M. pneu-moniae and estimation of its load are required. Therefore, a nested PCR assay for rapid and sensitive detection of M. pneumoniae in throat specimens was developed. The PCR assay was designed with an amplification control (AC) template to verify amplification from clinical specimens. The method was applied to the laboratory diagnosis of M. pneumoniae infection in a group of hospitalised patients, in patients who attended their general practitioner (GP) and in household contacts of patients with a positive PCR for M. pneumoniae. Subsequently, the M. pneumoniae load in the severely ill hospitalised patients and in the patients with relatively mild or no symptoms was estimated by applying the nested PCR to a series of limiting dilutions of nucleic acid isolated from throat swabs.
Materials and methods

Patients and throat sample preparation for nested PCR
Samples were obtained from patients admitted to hospital with community-acquired pneumonia, from patients visiting their GP because of a respiratory tract infection and from household contacts of M. pneumoniae DNA-positive patients in the hospitalised and nonhospitalised groups. Between Feb. 1997 and Aug. 1997 a total of 302 throat samples was collected from 62 hospitalised patients, 208 non-hospitalised patients and 32 household contacts. A further three follow-up throat samples were collected from asymptomatic, but M. pneumoniae-positive, household contacts 3 -4 weeks after the first sample. Patients who had to be hospitalised because of community-acquired respiratory tract infection were defined as more severely ill than non-hospitalised patients. Hospital nursing staff collected the throat swabs from the hospitalised patients and the GPs or their staff collected the throat swabs from the non-hospitalised patients. In the hospital as well as at the GP practices patients were sampled according to a standard protocol. Throat samples were collected on cotton-tipped swabs, which subsequently were agitated in 2 ml of transport medium (PPLObroth, yeast extract lo%, unheated horse serum 20%, glucose 0.5%, phenol red 0.002% and penicillin 1000 U/ml). A 200-pl sample of the transport medium in which the throat swab had been agitated was centrifuged at 12000 g for 30 min. The remaining 1.8 ml was stored at -70°C. Pellets were resuspended in 100 pl of lysis buffer (50 mM KC1, 10 m~ Tris-HC1, Table 1 . Primers used for the detection of M. pneumoniae DNA pH 8.3, NP40 0.45%, Tween 20 0.45%, proteinase K 10 mg/ml) (Boehringer Mannheim GmbH, Mannheim, Germany) and incubated at 50°C for 2 h. Subsequently, samples were heated at 95°C for 15 min to inactivate proteinase K. Ten pl of the lysed sample were used as template in the first reaction of the nested PCR (see below). The proteinase K protocol was used because the detection limits of M. pneumoniae DNA in throat swab specimens prepared by proteinase K lysis or by the more elaborate DNA extraction protocol of Boom et al. [16] were identical [17] .
Nested PCR protocol
A nested PCR for amplification of M. pneumoniae DNA was designed, based on the P1 cytadhesin gene PCR of Ursi et al. [18] . Primers P1-1 and P1-6 (Table  l) , which amplify a 272-bp fragment of the P1 gene, were used in the first PCR [19] . The nested primers P1-2 and P1-3 (Table 1 ) used in the second PCR amplify a 133-bp fragment. Primers were obtained from Perkin Elmer Applied Biosystems (Nieuwerkerk a/d IJssel, The Netherlands). Amplifications were performed in a final volume of 50 p l containing 10 m~ Tris-HC1 (PH 8.3), 50 mM KCl, 1.5 m M MgC12, 200 mM of each deoxynucleoside triphosphate (Perkin Elmer), 20 pmol of each primer, 1 U AmpliTaq DNA polymerase (Roche Molecular Systems, Branchburg, NJ, USA), 2 p l AC template and 10 pl of sample. Amplification was performed in a 9600 Thermocycler (Perkin Elmer) with a programme of 5 min at 95"C, followed by 30 cycles of 15 s at 95"C, 1 min at 65"C, 1.5 min at 72°C and a final step of 10 min at 72°C. One pl of the first PCR product was added to the reaction mixture of the second PCR. The second PCR was performed under the same conditions as the first PCR in a 20-cycle procedure. Ten pl of the reaction products were analysed on Metaphor agarose (FMC Bioproducts, Rockland, USA) 2% gels containing ethidium bromide 0.5 pg/ml for visualisation of amplicons by UV transillumination.
Prevention of PCR contamination
Preparation of the patient samples by lysis or DNA extraction and preparation of the PCR mixtures were performed in safety hoods equipped with U V germicidal lamps, in separate dedicated positive pressure laboratories performed in a third room. To check for crosscontamination of samples and for amplicon contamination during the procedure, negative controls were included after every fourth patient sample from the start of the preparation procedure. These negative controls consisted of transport medium without patient material and were processed in the same way as the patient samples. Pipetting of amplicons from the first into the second PCR reaction mixture was performed in a fourth room. During this part of the procedure gloves were changed after pipetting each sample. Finally, gel electrophoresis of the amplification products was performed in a fifth laboratory, located in a different building.
AC template for nested PCR
To enable detection of PCR inhibition in clinical specimens, an AC template was constructed for the nested PCR. The AC DNA template was a PCR product of the P1 gene into which had been inserted, between the sites recognised by the internal nested primers, a 210-bp sequence from the lacZ gene of Escherichia coii. As this target generates a longer PCR product than the naturally occurring template, it can be used to spike clinical specimens for PCR and produce a positive control band which can be distinguished easily from the natural product on the basis of size. The absence of the AC product in a spiked reaction thus signals the likely presence of PCR inhibitors in the clinical sample. Extended primers designated P 1-1 * -3') and P1-6" (5'-GGTGCTGCAGATCGCATTGCC GTCCTGCGTGG-3 ') containing terminal EcoRI and Pst I restriction sites, respectively, were used to amplifL a 292-bp P1 gene fragment from DNA of M. pneumoniae strain PI 1428. The reaction was performed with 1 ng of purified genomic DNA [16] as template and the PCR procedure was performed as described for the P1-1/P1-6 PCR. The PCR fragment was digested with EcoRI and PstI (Boehringer Mannheim), purified from a Metaphor agarose 2% gel with QiaEx (Qiagen GmbH, Hilden, Germany) and ligated to EcoRIand Pst I-digested plasmid pUCl8Sfi [20] . Enzymic reactions and transformation of E. coli were performed according to standard molecular biological procedures [21] . The ligation mixture was used to transform E. coli JM101 competent cells. From ampicillin-resistant transformants, plasmids were isolated with the Qiagen plasmid mini kit (Qiagen). One plasmid isolate, pMMl, containing the EcoRI-PstI gene fragment, was used in further experiments. A fragment of the E. coli lac2 gene (bp 815-1018) was amplified from plasmid pMP220 [22] with KpnI- In addition, the nested PCR was applied to throat swab specimens obtained from 10 volunteers, who had been without respiratory illness 1 month before and after throat swab sampling.
To assess the detection limit of the nested PCR, throat samples from healthy volunteers were spiked with M. pneumoniae strain MAC (7 X lo4 ch/ml) or strain PI 1428 (1.5 X lo6 cfu/ml). These spiked samples were serially diluted in 10-fold steps in transport medium, subjected to proteinase K lysis and the lysates were analysed in the nested PCR.
Semi-quantitative assessment of M. pneumoniae load in throat samples
There was sufficient material available to assess the M. pneumoniae load in 10 M. pneumoniae PCR-positive throat samples. To enable standardisation of the template input for the semi-quantitative PCR, total nucleic acid (NA) from 500 yl of the throat samples was extracted [16] and the concentration of purified NA was determined spectrophotometrically. NA concentrations were adjusted to 6 yg/ml for all samples; 10 yl of these adjusted samples and of 10-fold serial dilutions of the samples were used as input in the PCR. The highest 1 0-fold dilution which was PCR-positive was assumed to contain a number of cfu equal to the detection limit of the PCR. From this dilution, the number of M. pneumoniae cfu/yg of throat sample NA was calculated. Based on this value and the recorded concentration of NA in the original throat sample extract, the number of cfu/ml of throat sample was calculated.
Statistical analysis
Values of M. pneumoniae cfu(loglo)/ml in throat samples from hospitalised patients and non-hospitalised subjects were compared with the Student's t test.
Results
Primer speciJicity and detection limit of the nested PCR protocol in simulated clinical specimens
Specificity of the primer sets for M. pneumoniae DNA was confirmed by performing the nested PCR on various Mycoplasma spp., C. pneumoniae, L. pneumophila and on eight other bacteria commonly residing in the nasopharynx. The nested PCR was also performed on lysates of throat swab specimens from 10 healthy volunteers. None of these controls showed the M pneumoniae-specific signal (data not shown). The detection limit in the lysates of simulated clinical specimens corresponded to 0.6 and 1.3 cfu of strains MAC and PI-1428, respectively. These detection levels were highly reproducible: the detection was identical in five independent experiments performed at different times. Based on these data, the average detection limit was defined as 1 cfu of M. pneumoniae.
AmpliJication control
A final AC concentration of 0.07 fg/yl still allowed detectable amplification in the absence of M. pneumoniae DNA. In the presence of M. pneumoniae, this concentration of AC did not interfere with PCR detection of M. pneumoniae DNA in simulated clinical specimens (Fig. l) , i.e., the M. pneumoniae-specific signal was observed in the same dilutions in the presence or absence of the AC. 
Patients with M. pneumoniae-positive throat samples
Semi-quantitative assessment of M. pneumoniae load in throat samples
The M. pneumoniae load was assessed semi-quantitatively in 10 M. pneumoniae-positive throat samples, five from five hospitalised patients and five from four non-hospitalised subjects, the latter comprising two GP patients and two household contacts. Two samples were analysed from one household contact. The first sample was obtained when this subject was asymptomatic and a follow-up sample was obtained 3 weeks later when he had mild symptoms of respiratory infection. The second household contact was asymptomatic. The NA contents of throat sample varied between 1.0 and 2.3 yg/ml (mean 1.6). The nested PCR produced easily interpretable all-or-none signals in the dilution series. The highest dilutions that showed the M. pneumoniaespecific PCR signal (Fig. 2) patients was 2500 cfb/ml of throat sample, whereas the mean M. pneumoniae load in the non-hospitalised group was 100 cfb/ml of throat sample (Fig. 3) . The M. pneumoniae load in the first and second sample of the person who was asymptomatic at first sampling but became symptomatic after 2 weeks was only slightly different (260 and 170 cfu/ml of throat sample, respectively). The difference in cfb(loglo)/ml between the hospitalised and non-hospitalised group was 1.5 (95% CI 0.77-2.24) (p = 0.0016).
Discussion
In the present study a nested PCR for M. pneumoniae, with the target sequence in the P1 cytadhesin gene, was developed. This PCR protocol was applied to proteinase K lysates of throat swab specimens, to assess rapid laboratory diagnosis of M. pneumoniae infection. Sensitivity of detection of M. pneumoniae by PCR depends on the sample preparation method [13] , the primer pairs used [lo, 14,251, the type of clinical specimen on which the PCR is performed [26] , the use of genuine versus simulated clinical specimens [25] and signal enhancement by hybridisation after PCR [27] . Detection limits of 1.5-50 cfb, 10-100 colour changing units (ccu) and 5-50 fg of template DNA have been reported [3, 13, 14, 281 . This nested PCR allowed detection of 1 cfu of M. pneumoniae in proteinase K lysates of simulated M. pneumoniaepositive throat samples. In addition to a high sensitivity, the nested PCR protocol has the advantage of direct confirmation of the identity of the first PCR product, without the need for a time-consuming and labour-intensive hybridisation step. The risk of carryover contamination associated with nested PCR was minimised by performing all steps of the procedure in separate rooms. Negative controls included after each fourth test sample were PCR negative in all cases, indicating that contamination was effectively prevented.
Clinical samples may contain compounds that inhibit Taq polymerase [18, 26] ; many PCR protocols for detection of M. pneumoniae DNA lack an amplification control (AC) to check for such inhibition [9, 11,271. In the present study an AC template was constructed for Dilution (loglo) of purified throat sample the nested PCR protocol consisting of a P1-1/P1-6 M. pneumoniae P1 gene PCR fragment, enlarged by insertion of a 210-bp E. coli lac2 fragment. The concentration of this AC is critical: it has to be sufficiently high to generate a visible amplification product and sufficiently low not to interfere with the detection of M. pneumoniae DNA due to competition. A carefidly selected AC concentration of 0.07 fg/,d met both criteria (Fig. 1) . As inhibition was found in 20% of the samples investigated, the inclusion of an AC for diagnostic application of this PCR is essential. occurrence of respiratory tract infection and the time of throat sampling and the mean age was similar in the hospitalised and non-hospitalised groups, this finding suggests that more severe respiratory tract infection due to M. pneumoniae is associated with higher loads of M. pneumoniae in the throat. These results are in accordance with those of two other studies, in which the M. pneumoniae load was assessed in a semiquantitative way in throat specimens from symptomatic patients and asymptomatic controls. Kleemola [13] .
Although the total number of individuals studied is still small, the findings of the present study as well as those discussed above strongly suggest a relationship between M. pneumoniae load and severity of disease. The M. pneumoniae-positive subjects in the present study were identified in a population of 302 subjects. Avery large number of subjects would have to be studied to obtain a larger group of M. pneumoniae-positive hospitalised, non-hospitalised and asymptomatic persons.
In summary, a nested PCR protocol which allows the rapid, sensitive and specific detection of M. pneumoniae and the estimation of M. pneumoniae DNA load in throat swabs has been developed. With this method, a relationship between M. pneumoniae load in the throat and severity of disease was observed in a group of hospitalised patients, non-hospitalised patients and asymptomatic carriers .
